Search | VHL Regional Portal

Diagnostic testing and antibiotic utilization among inpatients evaluated for coronavirus disease 2019 (COVID-19) pneumonia.

Wimmer, Megan R; Griffin, Meggie; Peterson-Weber, Alex; Schulz, Lucas T; Hamel, Ashlee G; Schwei, Rebecca J; Fong, Karen; Burgess, Donna R; Brett, Meghan; Hale, Cory M; Holubar, Marisa; Jain, Rupali; Larry, Rachel; Spivak, Emily S; Newland, Helen; Njoku, Jessica; Postelnick, Michael; Walraven, Carla; Pulia, Michael S.

Infect Control Hosp Epidemiol ; 45(5): 667-669, 2024 May.

Article in English | MEDLINE | ID: mdl-38151334

ABSTRACT

We evaluated diagnostic test and antibiotic utilization among 252 patients from 11 US hospitals who were evaluated for coronavirus disease 2019 (COVID-19) pneumonia during the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant pandemic wave. In our cohort, antibiotic use remained high (62%) among SARS-CoV-2-positive patients and even higher among those who underwent procalcitonin testing (68%).

Subject(s)

COVID-19 , Pneumonia , Humans , Inpatients , SARS-CoV-2 , Diagnostic Techniques and Procedures , Anti-Bacterial Agents , COVID-19 Testing

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL